Early intervention for bipolar disorder: Current imperatives, future directions;Intervenção precoce no transtorno bipolar: Necessidades atuais, rumos futuros

Revista Brasileira de Psiquiatria

Volumn 33, Issue SUPPL. 2, 2011, Pages

  Taylor, Matthew ^a   Bressan, Rodrigo Affonseca ^b   Neto, Pedro Pan ^b   Brietzke, Elisa ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bipolar disorder; Determination; Early intervention; Review; Treatment outcome

Indexed keywords

ALCOHOL ABUSE; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BORDERLINE STATE; COMORBIDITY; COMPARATIVE STUDY; DELAYED DIAGNOSIS; DEPRESSION; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; FAMILY HISTORY; FOLLOW UP; HUMAN; MAJOR DEPRESSION; MANIA; MENTAL INSTABILITY; META ANALYSIS (TOPIC); MORTALITY; MULTICENTER STUDY (TOPIC); ONSET AGE; PHARMACEUTICAL CARE; PREVALENCE; RISK ASSESSMENT; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR; SYSTEMATIC REVIEW (TOPIC);

BIPOLAR DISORDER; DISEASE PROGRESSION; EARLY DIAGNOSIS; EARLY MEDICAL INTERVENTION; HUMANS; RECURRENCE; RISK; SUICIDE;

EID: 84856988603     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462011000600006     Document Type: Article

References (81)

1. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, Kessler RC. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007;64(5):543-552.
2. Merikangas KR, Jin R, He J-P, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, Posada-Villa J, Sagar R, Wells JE, Zarkov Z. Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative. Arch Gen Psychiatry. 2011;68(3):241-251.
3. Osby U, Brandt L, Correia N, Ekbom A, Sparén P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry. 2001;58(9):844-850.
4. Høyer EH, Mortensen PB, Olesen AV. Mortality and causes of death in a total national sample of patients with afective disorders admitted for the frst time between 1973 and 1993. Br J Psychiatry. 2000;176:76-82.
5. Dutta R, Boydell J, Kennedy N, Van Os J, Fearon P, Murray RM. Suicide and other causes of mortality in bipolar disorder: a longitudinal study. Psychol Med. 2007;37(6):839-847.
6. Novick DM, Swartz HA, Frank E. Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence. Bipolar Disord. 2010;12(1):1-9.
7. Baldessarini RJ, Bolzani L, Cruz N, Jones PB, Lai M, Lepri B, Perez J, Salvatore P, Tohen M, Tondo L, Vieta E. Onset-age of bipolar disorders at six international sites. J Afect Disord. 2010;121(1-2):143-146.
8. Hamshere ML, Gordon-Smith K, Forty L, Jones L, Caesar S, Fraser C, Hyde S, Tredget J, Kirov G, Jones I, Craddock N, Smith DJ. Age-at-onset in bipolar-I disorder: mixture analysis of 1369 cases identifes three distinct clinical sub-groups. J Afect Disord. 2009;116(1-2):23-29.
9. Tohen M, Zarate CA Jr, Hennen J, Khalsa HM, Strakowski SM, Gebre-Medhin P, Salvatore P, Baldessarini RJ. Te McLean-Harvard First-Episode Mania Study: prediction of recovery and frst recurrence. Am J Psychiatry. 2003;160(12):2099-2107.
10. Yatham LN, Kauer-Sant'Anna M, Bond DJ, Lam RW, Torres I. Course and outcome after the frst manic episode in patients with bipolar disorder: prospective 12-month data from the Systematic Treatment Optimization Program For Early Mania project. Can J Psychiatry. 2009;54(2):105-112.
11. Baldessarini RJ, Salvatore P, Khalsa HMK, Gebre-Medhin P, Imaz H, González-Pinto A, Perez J, Cruz N, Maggini C, Tohen M. Morbidity in 303 frst-episode bipolar I disorder patients. Bipolar Disord. 2010;12(3):264-270.
12. Forty L, Jones L, Jones I, Smith DJ, Caesar S, Fraser C, Gordon-Smith K, Hyde S, Craddock N. Polarity at illness onset in bipolar I disorder and clinical course of illness. Bipolar Disord. 2009;11(1):82-88.
13. Suppes T, Leverich GS, Keck PE, Nolen WA, Denicof KD, Altshuler LL, McElroy SL, Rush AJ, Kupka R, Frye MA, Bickel M, Post RM. Te Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the frst 261 patients. J Afect Disord. 2001;67(1-3):45-59.
14. Hirschfeld RMA, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry. 2003;64(2):161-174.
15. Berk M, Dodd S, Callaly P, Berk L, Fitzgerald P, de Castella AR, Filia S, Filia K, Tahtalian S, Bifn F, Kelin K, Smith M, Montgomery W, Kulkarni J. History of illness prior to a diagnosis of bipolar disorder or schizoafective disorder. J Afect Disord. 2007;103(1-3):181-186.
16. Gazalle FK, Andreazza AC, Ceresér KM, Hallal PC, Santin A, Kapczinski F. Clinical impact of late diagnose of bipolar disorder. J Afect Disord. 2005;86(2-3):313-316.
17. Post RM, Leverich GS, Kupka RW, Keck PE Jr, McElroy SL, Altshuler LL, Frye MA, Luckenbaugh DA, Rowe M, Grunze H, Suppes T, Nolen WA. Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. J Clin Psychiatry. 2010;71(7):864-872.
18. Goldberg J F, Ernst CL. Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder. J Clin Psychiatr y. 2002;63(11):985-991.
19. McCombs JS, Ahn J, Tencer T, Shi L. Te impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis. J Afect Disord. 2007;97(1-3):171-179.
20. Mitchell PB, Goodwin GM, Johnson GF, Hirschfeld RMA. Diagnostic guidelines for bipolar depression: a probabilistic approach. Bipolar Disord. 2008;10(1 Pt 2):144-152.
21. Mitchell PB, Frankland A, Hadzi-Pavlovic D, Roberts G, Corry J, Wright A, Loo CK, Breakspear M. Comparison of depressive episodes in bipolar disorder and in major depressive disorder within bipolar disorder pedigrees. Br J Psychiatry. In press 2011.
22. Forty L, Smith D, Jones L, Jones I, Caesar S, Cooper C, Fraser C, Gordon-Smith K, Hyde S, Farmer A, McGufn P, Craddock N. Clinical diferences between bipolar and unipolar depression. Br J Psychiatry. 2008;192(5):388-389.
23. Angst J, Adolfsson R, Benazzi F, Gamma A, Hantouche E, Meyer TD, Skeppar P, Vieta E, Scott J. Te HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. J Afect Disord. 2005;88(2):217-233.
24. Ghaemi SN, Miller CJ, Berv DA, Klugman J, Rosenquist KJ, Pies RW. Sensitivity and specifcity of a new bipolar spectrum diagnostic scale. J Afect Disord. 2005;84(2-3):273-277.
25. Smith DJ, Griffiths E, Kelly M, Hood K, Craddock N, Simpson SA. Unrecognised bipolar disorder in primary care patients with depression. Br J Psychiatry. 2011;199:49-56.
26. Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rössler W. Toward a re-defnition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J Afect Disord. 2003;73(1-2):133-146.
27. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593-602.
28. Angst J, Cui L, Swendsen J, Rothen S, Cravchik A, Kessler RC, Merikangas KR. Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication. Am J Psychiatry. 2010;167(10):1194-1201.
29. Salvatore P, Baldessarini RJ, Tohen M, Khalsa HM, Sanchez-Toledo J P, Zarate CA Jr, Vieta E, Maggini C. McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 frst-episode psychotic disorder patients. J Clin Psychiatry. 2009;70(4):458-466.
30. Merikangas KR, Herrell R, Swendsen J, Rössler W, Ajdacic-Gross V, Angst J. Specifcity of Bipolar Spectrum Conditions in the Comorbidity of Mood and Substance Use Disorders: Results From the Zurich Cohort Study. Arch Gen Psychiatry. 2008;65(1):47-52.
31. Correll CU, Smith CW, Auther AM, McLaughlin D, Shah M, Foley C, Olsen R, Lencz T, Kane JM, Cornblatt BA. Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specifed considered at very high risk for schizophrenia. J Child Adolesc Psychopharmacol. 2008;18(5):475-490.
32. Grant BF, Stinson FS, Hasin DS, Dawson DA, Chou S P, Ruan WJ, Huang B. Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2005;66(10):1205-1215.
33. Gunderson JG, Weinberg I, Daversa MT, Kueppenbender KD, Zanarini MC, Shea MT, Skodol AE, Sanislow CA, Yen S, Morey LC, Grilo CM, McGlashan TH, Stout RL, Dyck I. Descriptive and longitudinal observations on the relationship of borderline personality disorder and bipolar disorder. Am J Psychiatry. 2006;163(7):1173-1178.
34. Kraepelin E. Lifetime Editions of Kraepelin in English. Bristol: Toemmes Press; 2002.
35. Kessing LV, Andersen PK, Mortensen PB, Bolwig TG. Recurrence in afective disorder. I. Case register study. Br J Psychiatry. 1998;172:23-28.
36. Kessing LV, Hansen MG, Andersen PK. Course of illness in depressive and bipolar disorders. Naturalistic study, 1994-1999. Br J Psychiatry. 2004;185:372-377.
37. Kessing LV, Hansen MG, Andersen PK, Angst J. The predictive efect of episodes on the risk of recurrence in depressive and bipolar disorders - a life-long perspective. Acta Psychiatr Scand. 2004;109(5):339-344.
38. Robinson LJ, Ferrier IN. Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disord. 2006;8(2):103-116.
39. Torres IJ, DeFreitas CM, DeFreitas VG, Bond DJ, Kunz M, Honer WG, Lam RW, Yatham LN. Relationship between cognitive functioning and 6-month clinical and functional outcome in patients with frst manic episode bipolar I disorder. Psychol Med. 2011;41(5):971-982.
40. Rosa AR, Reinares M, Franco C, Comes M, Torrent C, Sánchez-Moreno J, Martínez-Arán A, Salamero M, Kapczinski F, Vieta E. Clinical predictors of functional outcome of bipolar patients in remission. Bipolar Disord. 2009;11(4):401-409.
41. Berk M, Brnabic A, Dodd S, Kelin K, Tohen M, Malhi GS, Berk L, Conus P, McGorry PD. Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord. 2011;13(1):87-98.
42. Bratti IM, Baldessarini RJ, Baethge C, Tondo L. Pretreatment episode count and response to lithium treatment in manic-depressive illness. Harv Rev Psychiatry. 2003;11(5):245-256.
43. Scott J, Colom F, Vieta E. A meta-analysis of relapse rates with adjunctive psychological therapies compared to usual psychiatric treatment for bipolar disorders. Int J.Neuropsychopharmacol. 2007;10(1):123-129.
44. Kempton MJ, Geddes JR, Ettinger U, Williams SCR, Grasby PM. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry. 2008;65(9):1017-1032.
45. Hallahan B, Newell J, Soares JC, Brambilla P, Strakowski SM, Fleck DE, Kieseppä T, Altshuler LL, Fornito A, Malhi GS, McIntosh AM, Yurgelun-Todd DA, Labar KS, Sharma V, MacQueen GM, Murray RM, McDonald C. Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. Biol Psychiatry. 2011;69(4):326-335.
46. Post RM, Weiss SR. A speculative model of afective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures. Mol Neurobiol. 1996;13(1):33-60.
47. Post RM. Kindling and sensitization as models for afective episode recurrence, cyclicity, and tolerance phenomena. Neurosci Biobehav Rev. 2007;31(6):858-873.
48. Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J, Kauer-Sant'anna M, Grassi-Oliveira R, Post RM. Allostatic load in bipolar disorder: Implications for pathophysiology and treatment. Neurosci Biobehav Rev. 2008;32(4):675-692.
49. Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yücel M, Gama CS, Dodd S, Dean B, Magalhães PV, Amminger P, McGorry P, Malhi GS. Pathways underlying neuroprogression in bipolar disorder: focus on infammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev. 2011;35(3):804-817.
50. Kapczinski F, Frey BN, Kauer-Sant'Anna M, Grassi-Oliveira R. Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Rev Neurother. 2008;8(7):1101-1113.
51. Stork C, Renshaw PF. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry. 2005;10(10):900-919.
52. Andreazza AC, Kauer-Sant'anna M, Frey BN, Bond DJ, Kapczinski F, Young LT, Yatham LN. Oxidative stress markers in bipolar disorder: a meta-analysis. J Afect Disord. 2008;111(2-3):135-144.
53. Goodwin GM. Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology. J Psychopharmacol. (Oxford). 2009;23(4):346-388.
54. Beynon S, Soares-Weiser K, Woolacott N, Dufy S, Geddes JR. Psychosocial interventions for the prevention of relapse in bipolar disorder: systematic review of controlled trials. Br J Psychiatry. 2008;192(1):5-11.
55. Weiss RD, Ostacher MJ, Otto MW, et al. Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry. 2005;66(6):730-735; quiz 808-809.
56. Sachs GS, Tase ME, Otto MW, Bauer M, Miklowitz D, Wisniewski SR, Lavori P, Lebowitz B, Rudorfer M, Frank E, Nierenberg AA, Fava M, Bowden C, Ketter T, Marangell L, Calabrese J, Kupfer D, Rosenbaum JF. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry. 2003;53(11):1028-1042.
57. van der Loos MLM, Mulder P, Hartong EGTM, Blom MB, Vergouwen AC, van Noorden MS, Timmermans MA, Vieta E, Nolen WA; LamLit Study Group. Efcacy and safety of two treatment algorithms in bipolar depression consisting of a combination of lithium, lamotrigine or placebo and paroxetine. Acta Psychiatr Scand. 2010;122(3):246-254.
58. Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, Morriss R, Alder N, Juszczak E. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet. 2010;375(9712):385-395.
59. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, Kasper S. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J. Biol. Psychiatry. 2010;11(2):81-109.
60. Kauer-Sant'Anna M, Bond DJ, Lam RW, Yatham LN. Functional outcomes in frst-episode patients with bipolar disorder: a prospective study from the Systematic Treatment Optimization Program for Early Mania project. Compr Psychiatry. 2009;50(1):1-8.
61. Grunze H, Kasper S, Goodwin G, Bowden C, Möller HJ. Te World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J Biol Psychiatry. 2004;5(3):120-135.
62. Cipriani A, Pretty H, Hawton K, Geddes JR. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry. 2005;162(10):1805-1819.
63. Colom F, Vieta E, Sánchez-Moreno J, Palomino-Otiniano R, Reinares M, Goikolea JM, Benabarre A, Martínez-Arán A. Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial. Br J Psychiatry. 2009;194(3):260-265.
64. Petersen L, Jeppesen P, Torup A, Abel MB, Ohlenschlaeger J, Christensen TØ, Krarup G, Jørgensen P, Nordentoft M. A randomised multicentre trial of integrated versus standard treatment for patients with a frst episode of psychotic illness. BMJ. 2005;331(7517):602.
65. Gafoor R, Landau S, Craig TKJ, Elanjithara T, Power P, McGuire P. Esquire trial: efcacy and adverse efects of quetiapine versus risperidone in frst-episode schizophrenia. J Clin Psychopharmacol. 2010;30(5):600-606.
66. Kessing LV, Hansen HV, Christensen EM, Dam H, Gluud C, Wetterslev J. The efects of centralised and specialised combined pharmacological and psychological intervention compared with decentralised and non-specialised treatment in the early course of severe unipolar and bipolar afective disorders--design of two randomised clinical trials. Trials. 2011;12(1):32.
67. Berk M, Conus P, Lucas N, Hallam K, Malhi GS, Dodd S, Yatham LN, Yung A, McGorry P. Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord. 2007;9(7):671-678.
68. Howes OD, Lim S, Teologos G, Yung AR, Goodwin GM, McGuire P. A comprehensive review and model of putative prodromal features of bipolar afective disorder. Psychol Med. 2011;41(8):1567-1577.
69. Skjelstad DV, Malt U F, Holte A. Symptoms and signs of the initial prodrome of bipolar disorder: a systematic review. J Afect Disord. 2010;126(1-2):1-13.
70. Olvet DM, Stearns WH, McLaughlin D, Auther AM, Correll CU, Cornblatt BA. Comparing clinical and neurocognitive features of the schizophrenia prodrome to the bipolar prodrome. Schizophr Res. 2010;123(1):59-63.
71. Craddock N, Sklar P. Genetics of bipolar disorder: successful start to a long journey. Trends Genet. 2009;25(2):99-105.
72. McGufn P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A. The heritability of bipolar afective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry. 2003;60(5):497-502.
73. Kieseppa T, Partonen T, Haukka J, Kaprio J, Lonnqvist J. High Concordance of Bipolar I Disorder in a Nationwide Sample of Twins. Am J Psychiatry. 2004;161(10):1814-1821.
74. Craddock N, Jones I. Genetics of bipolar disorder. J Med Genet. 1999;36(8):585-594.
75. DelBello M P, Geller B. Review of studies of child and adolescent ofspring of bipolar parents. Bipolar Disord. 2001;3(6):325-334.
76. Birmaher B, Axelson D, Monk K, Kalas C, Goldstein B, Hickey MB, Obreja M, Ehmann M, Iyengar S, Shamseddeen W, Kupfer D, Brent D. Lifetime psychiatric disorders in school-aged ofspring of parents with bipolar disorder: the Pittsburgh Bipolar Ofspring study. Arch Gen Psychiatry. 2009;66(3):287-296.
77. Zappitelli MC, Bordin IA, Hatch J P, Caetano SC, Zunta-Soares G, Olvera RL, Soares JC. Lifetime psychopathology among the ofspring of Bipolar I parents. Clinics (Sao Paulo). 2011;66(5):725-730.
78. Bechdolf A, Nelson B, Cotton SM, Chanen A, Tompson A, Kettle J, Conus P, Amminger G P, Yung AR, Berk M, McGorry PD. A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults. J Afect Disord. 2010;127(1-3):316-320.
79. Chang KD, Dienes K, Blasey C, Adleman N, Ketter T, Steiner H. Divalproex monotherapy in the treatment of bipolar ofspring with mood and behavioral disorders and at least mild afective symptoms. J Clin Psychiatry. 2003;64(8):936-942.
80. DelBello M P, Adler CM, Whitsel RM, Stanford KE, Strakowski SM. A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder. J Clin Psychiatry. 2007;68(5):789-795.
81. Miklowitz DJ, Chang KD, Taylor DO, George EL, Singh MK, Schneck CD, Dickinson LM, Howe ME, Garber J. Early psychosocial intervention for youth at risk for bipolar I or II disorder: a one-year treatment development trial. Bipolar Disord. 2011;13(1):67-75.